Pathological mechanisms and clinical features of eosinophilic chronic rhinosinusitis in the Japanese population

Allergology International

Volumn 59, Issue 3, 2010, Pages 247-256

  Takeno, Sachio ^a   Hirakawa, Katsuhiro ^a   Ishino, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Endoscopic sinus surgery; Eosinophilic chronic rhinosinusitis; Glucocorticoids; Toll like receptor; Transcription factors

Indexed keywords

EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; STEROID;

CELL INFILTRATION; CLINICAL FEATURE; EOSINOPHILIA; EOSINOPHILIC CHRONIC RHINOSINUSITIS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; JAPAN; PARANASAL SINUS; PRIORITY JOURNAL; RELAPSE; REVIEW; RHINOSINUSITIS; SENSITIZATION; SINUSITIS; UPREGULATION;

EID: 77957239349     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-RAI-0202     Document Type: Review

References (66)

1. Meltzer EO, Hamilos DL, Hadley JA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114(6 Suppl):155-212.
2. Scadding GK, Durham SR, Mirakianz R et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2007;38:260-75.
3. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007;20:1-136.
4. Jankowski R, Bouchoua F, Coffinet L, Vignaud JM. Clinical factors influencing the eosinophil infiltration of nasal polyps. Rhinology 2002;40:173-8.
5. Demoly P, Crampette L, Mondain M et al. Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol 1994;94:95-108.
6. Hamilos DL. Chronic sinusitis. J Allergy Clin Immunol 2000;106:213-27.
7. Danese M, Duvoisin B, Agrifoglio A, Cherpillod J, Krayenbuhl M. [Influence of naso-sinusal anatomic variants on recurrent, persistent or chronic sinusitis. X-ray computed tomographic evaluation in 112 patients]. J Radiol 1997;78: 651-7 (in French).
8. Hoover GE, Newman LJ, Platts-Mills TA, Phillips CD, Gross CW, Wheatley LM. Chronic sinusitis: risk factors for extensive disease. J Allergy Clin Immunol 1997;100: 185-91.
9. Watelet JB, Demetter P, Claeys C et al. Wound healing after paranasal sinus surgery: neutrophilic inflammation influences the outcome. Histopathology 2006;48:174-81.
10. Zadeh MH, Banthia V, Anand VK et al. Significance of eosinophilia in chronic rhinosinusitis. Am J Rhinol 2002; 16:313-7.
11. Haruna S, Otori N, Moriyama H et al. Olfactory dysfunction in sinusitis with infiltration of numerous activated eosinophils. Auris Nasus Larynx 2006;33:23-30.
12. Szucs E, Ravandi S, Goossens A et al. Eosinophilia in the ethmoid mucosa and its relationship to the severity of inflammation in chronic rhinosinusitis. Am J Rhinol 2002; 16:131-4.
13. Takeno S, Yajin K, Hisayuki A et al. Comparison of local cytokine gene expression and the distribution of eosinophils and CD4-positive cell subsets in the paranasal sinus mucosa between atopic and non atopic subjects. Allergol Int 2004;53:135-44.
14. Berger G, Kattan A, Bernheim J, Ophir D. Polypoid mucosa with eosinophilia and glandular hyperplasia in chronic sinusitis: a histopathological and immunohistochemical study. Laryngoscope 2002;112:738-45.
15. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-63.
16. Ponikau JU, Sherris DA, Kephart GM et al. Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis. J Allergy Clin Immunol 2005;116:362-9.
17. Shleimer RP, Lane AP, Kim J. Innate and acquired immunity and epithelial cell function in chronic rhinosinusitis. Clin Allergy Immunol 2007;20:51-78.
18. Yao T, Kojima Y, Koyanagi A et al. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope 2009;119:1053-9.
19. Cao PP, Li HB, Wang BF et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124:478-84.
20. Kim JW, Hong SL, Kim YK, Lee CH, Min YG, Rhee CS. Histological and immunological features of non- eosinophilic nasal polyps. Otolaryngol Head Neck Surg 2007; 137:925-30.
21. Wakashin H, Hirose K, Maezawa Y et al. IL-23 and Th17 cells enhance Th2 cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008;178: 1023-32.
22. Kamil A, Graffer O, Lavigne F, Taha R, Renzi PM, Hamid Q. Comparison of inflammatory cell profile and Th2 cytokine expression in the ethmoid sinus, maxillary sinus, and turbinate of atopic subjects with chronic sinusitis. Otolaryngol Head Neck Surg 1998;118:804-9.
23. Ramadan HH, Fornelli R, Ortiz AO, Rodman S. Correlation of allergy and severity of sinus disease. Am J Rhinol 1999;13:345-7.
24. Emanuel IA, Shah SB. Chronic rhinosinusitis: allergy and sinus computed tomography relationships. Otolaryngol Head Neck Surg 2000;123:687-91.
25. Mucha SM, Baroody FM. Sinusitis update. Curr Opin Allergy Clin Immunol 2003;3:33-8.
26. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607-14.
27. Christodoulopoulos P, Cameron L, Durham S, Hamid Q. Molecular pathology of allergic disease. II: Upper airway disease. J Allergy Clin Immunol 2000;105:211-23.
28. Elwany S, Bassyouni M, Morad F. Some risk factors for refractory chronic sinusitis: an immunohistochemical and electron microscopic study. J Laryngol Otol 2002;116:112-5.
29. Driscoll PV, Naclerio RM, Baroody FM. CD4+ lymphocytes are increased in the sinus mucosa of children with chronic sinusitis. Arch Otolaryngol Head Neck Surg 1996; 122:1071-6.
30. Jyonouchi H, Sun S, Kelly A, Rimell FL. Effects of exogenous interferon gamma on patients with treatmentresistant chronic rhinosinusitis and dysregulated interferon gamma production: a pilot study. Arch Otolaryngol Head Neck Surg 2003;129:563-9.
31. Qin S, Rottman JB, Myers P et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101:746-54.
32. Imai T, Nagira M, Takagi S et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999;11:81-8.
33. Terada N, Gorai S, Jeong KW, Nomura T, Numata T, Konno A. Mechanisms of eosinophilic inflammation in the mucosa of the nasal cavity and paranasal sinus. Allergol Int 2001;50:171-7.
34. Ooi EH, Wormald PJ, Tan LW. Innate immunity in the paranasal sinuses: a review of nasal host defenses. Am J Rhinol 2008;22:13-9.
35. Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 2006;20:138-44.
36. Sachse F, von Eiff C, Stoll W, Becker K, Rudack C. Induction of CXC chemokines in A549 airway epithelial cells by trypsin and staphylococcal proteases-a possible route for neutrophilic inflammation in chronic rhinosinusitis. Clin Exp Immunol 2006;144:534-42.
37. Takeno S, Hirakawa K, Ueda T, Furukido K, Osada R, Yajin K. Nuclear factor-kappa B activation in the nasal polyp epithelium: Relationship to local cytokine gene expression. Laryngoscope 2002;112:53-8.
38. Harada K, Isse K, Nakamura Y. Interferon gamma accelerates NF-kappa B activation of biliary epithelial induced by Toll-like receptor and ligand interaction. J Clin Pathol 2006;59:184-90.
39. Osada R, Takeno S, Hirakawa K et al. Expression and localization of nuclear factor-kappa B subunits in cultured human paranasal sinus mucosal cells. Rhinology 2003;41: 80-6.
40. Ramis I, Bioque G, Lorente J et al. Constitutive nuclear factor-κB activity in human upper airway tissue and nasal epithelial cells. Eur Respir J 2000;15:582-9.
41. Dong Z, Yang Z, Wang C. Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway. Am J Rhinol 2005;19:236-9.
42. Lane AP, Truong-Tran QA, Myers A, Bickel C, Schleimer RP. Serum amyloid A, properdin, complement 3, and tolllike receptors are expressed locally in human sinonasal tissure. Am J Rhinol 2006;20:117-23.
43. Nishi Y, Takeno S, Ishino T, Hirakawa K. Glucocorticoids suppress NF-kB activation induced by LPS and PGN in paranasal sinus epithelial cells. Rhinology 2009;47:413-8.
44. Homma T, Kato A, Hashimoto N et al. Corticosteroid and cytokines synergistically enhance toll-Like receptor 2 expression in respiratory epithelial cells. Am J Respir Cell Mol Biol 2004;31:463-9.
45. Chinenov Y, Rogatsky I. Glucocorticoids and the innate immune system: Crosstalk with the toll-like receptor signaling network.Mol Cell Endocrinol 2007;275:30-42.
46. Haruna S, Shimada C, Ozawa M, Fukami S, Moriyama H. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. Rhinology 2009;47:66-71.
47. Steinke JW, Bradley D, Arango P. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: Importance to eosinophilia and asthma. J Allergy Clin Immunol 2003;112:342-9.
48. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347:1493-9.
49. Shirasaki H, Kanaizumi E, Watanabe K et al. Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy 2002;32:1007-12.
50. Ragab S, Parikh A, Darby YC, Scadding GK. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001;31:1385-91.
51. Kütting B, Nieschalk M, Brehler R. A new concept for treatment of sinonasal polyposis. Allergy 2000;55:1091-2.
52. Angeli A, Masera RG, Sartori ML et al. Modulation by cytokines of glucocorticoid action. Ann N Y Acad Sci 1999; 876:210-20.
53. Göttlicher M, Heck S, Herrlich P. Transcriptional crosstalk, the second mode of steroid hormone receptor action. J Mol Med 1998;76:480-9.
54. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 2008;63:1292-300.
55. Choi BR, Kwon JH, Gong SJ et al. Expression of glucocorticoid receptor mRNA in glucocorticoid-resistant nasal polyps. Exp Mol Med 2006;38:466-73.
56. Pujols L, Mullol J, Benítez P et al. Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells. Respir Med 2003; 97:90-6.
57. Hamilos DL, Leung DYM, Muro S et al. GRß expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 2001;108:59-68.
58. Gougat C, Jaffuel D, Gagliardo R et al. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-κB activities hormone independently. J Mol Med 2002;80:309-18.
59. Valera FC, Queiroz R, Scrideli C et al. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clin Exp Allergy 2009;39:81-8.
60. Small CB, Hernandez J, Reyes A et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol 2005;116:1275-81.
61. Stjarne P, Mosges R, Jorissen M et al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg 2006;132:179-85.
62. Takeno S, Takeda K, Nishi Y, Ishino T, Hirakawa K. Clinical effectiveness of local application of beclomethasone dipropionate dry powder for the treatment of chronic rhinosinusitis with eosinophil infiltration. Nihon Bika Gakkai Kaishi [Jpn J Rhinol] 2007;46:102-8 (in Japanese).
63. Hissaria P, Smith W, Wormald PJ et al. Short course of systemic corticosteroids in sinonasal polyposis: a doubleblind, randomized, placebocontrolled trial with evaluation of outcome measures. J Allergy Clin Immunol 2006;118: 128-33.
64. Sieskiewicz A, Olszewska E, Rogowski M, Grycz E. Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: a preliminary investigation. Ann Otol Rhinol Laryngol 2006;115:490-4.
65. Myller JP, Toppila-Salmi SK, Toppila EM et al. Mucosal eosinophils and l-selectin ligands are associated with invasive and noninvasive sinus surgery outcomes. Am J Rhinol Allergy 2009;23:21-7.
66. Matsuwaki Y, Ookushi T, Asaka D et al. Chronic rhinosinusitis: risk factors for the recurrence of chronic rhinosinusitis based on 5-year follow-up after endoscopic sinus surgery. Int Arch Allergy Immunol 2008;146 (Suppl 1):77-81.